Krognes Steve E.
SEC CIK 1666236 · EDGAR
BoughtSold
Most active insiders at GH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Talasaz AmirAli | Co-CEO, Dir | — | $84.25M |
| 2 | Eltoukhy Helmy | Co-CEO, Dir | — | $22.03M |
| 3 | Freeman Chris | Chief Commercial Off | — | $16.92M |
| 4 | Monroe Terilyn J. | CHRO | — | $15.95M |
| 5 | Bell Michael Brian | CFO | — | $8.81M |
| 6 | CLARK IAN T | Dir | — | $6.06M |
| 7 | Kalia Kumud | CIO | $78.5K | $5.91M |
| 8 | Chudova Darya | CTO | — | $4.36M |
| 9 | Saia John G. | CLO | — | $4.25M |
| 10 | Krognes Steve E. | Dir | — | $2.40M |
Transactions 65
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-09-17 17:10 | 2026-09-16 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | S - Sale | $175.74 | -6,674 | 7,906 | -46% | -$1.17M |
| D | 2026-07-02 18:07 | 2026-06-30 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | M - OptEx | $0.00 | +155 | 14.6K | +1% | $0 |
| D | 2026-06-22 17:53 | 2026-06-17 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | M - OptEx | $0.00 | +4,203 | 14.4K | +41% | $0 |
| 2026-06-05 19:50 | 2026-06-04 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | S - Sale | $132.51 | -9,294 | 10.2K | -48% | -$1.23M | |
| D | 2026-06-05 16:45 | 2026-06-03 | DNLI | Denali Therapeutics Inc. | Krognes Steve E. | Dir | A - Grant | $0.00 | +6,408 | 38.2K | +20% | $0 |
| D | 2026-06-01 17:30 | 2026-05-31 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | M - OptEx | $0.00 | +154 | 19.5K | +0.8% | $0 |
| D | 2026-05-01 17:45 | 2026-04-30 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | M - OptEx | $0.00 | +154 | 19.4K | +0.8% | $0 |
| D | 2026-04-01 17:31 | 2026-03-31 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | M - OptEx | $0.00 | +155 | 19.2K | +0.8% | $0 |
| D | 2026-03-02 | 2026-02-28 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | M - OptEx | $0.00 | +154 | 19.1K | +0.8% | $0 |
| D | 2026-02-02 | 2026-01-31 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | M - OptEx | $0.00 | +154 | 18.9K | +0.8% | $0 |
| D | 2026-01-05 | 2025-12-31 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | M - OptEx | $0.00 | +154 | 18.7K | +0.8% | $0 |
| D | 2025-12-01 | 2025-11-30 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | M - OptEx | $0.00 | +155 | 18.6K | +0.8% | $0 |
| D | 2025-11-03 | 2025-10-31 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | M - OptEx | $0.00 | +154 | 18.4K | +0.8% | $0 |
| D | 2025-10-02 | 2025-09-30 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | M - OptEx | $0.00 | +154 | 18.3K | +0.8% | $0 |
| D | 2025-09-03 | 2025-08-31 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | M - OptEx | $0.00 | +155 | 18.1K | +0.9% | $0 |
| D | 2025-08-04 | 2025-07-31 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | M - OptEx | $0.00 | +154 | 18.0K | +0.9% | $0 |
| D | 2025-07-02 | 2025-06-30 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | M - OptEx | $0.00 | +154 | 17.8K | +0.9% | $0 |
| D | 2025-06-16 | 2025-06-12 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | M - OptEx | $0.00 | +6,674 | 17.7K | +61% | $0 |
| D | 2025-06-05 | 2025-06-03 | DNLI | Denali Therapeutics Inc. | Krognes Steve E. | Dir | A - Grant | $0.00 | +6,037 | 31.8K | +23% | $0 |
| D | 2025-06-02 | 2025-05-31 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | M - OptEx | $0.00 | +154 | 11.0K | +1% | $0 |
| D | 2025-05-01 | 2025-04-30 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | M - OptEx | $0.00 | +155 | 10.8K | +1% | $0 |
| D | 2025-04-02 | 2025-03-31 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | M - OptEx | $0.00 | +154 | 10.7K | +1% | $0 |
| D | 2025-03-04 | 2025-02-28 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | M - OptEx | $0.00 | +154 | 10.5K | +1% | $0 |
| D | 2025-02-04 | 2025-01-31 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | M - OptEx | $0.00 | +154 | 10.4K | +2% | $0 |
| 2025-01-08 | 2025-01-07 | DNLI | Denali Therapeutics Inc. | Krognes Steve E. | Dir | S - Sale | $20.81 | -3,339 | 25.8K | -11% | -$69.5K | |
| 2025-01-03 | 2024-12-31 | DNLI | Denali Therapeutics Inc. | Krognes Steve E. | Dir | S - Sale | $20.25 | -30.0K | 29.1K | -51% | -$607.5K | |
| D | 2025-01-02 | 2024-12-31 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | M - OptEx | $0.00 | +155 | 10.2K | +2% | $0 |
| D | 2024-12-02 | 2024-11-30 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | M - OptEx | $0.00 | +154 | 10.1K | +2% | $0 |
| D | 2024-11-04 | 2024-10-31 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | M - OptEx | $0.00 | +154 | 9,911 | +2% | $0 |
| 2024-10-02 | 2024-09-30 | DNLI | Denali Therapeutics Inc. | Krognes Steve E. | Dir | S - Sale | $29.03 | -30.0K | 29.1K | -51% | -$870.9K | |
| D | 2024-10-01 | 2024-09-30 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | M - OptEx | $0.00 | +154 | 9,757 | +2% | $0 |
| D | 2024-09-03 | 2024-08-31 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | M - OptEx | $0.00 | +155 | 9,603 | +2% | $0 |
| 2024-08-22 | 2024-08-20 | DNLI | Denali Therapeutics Inc. | Krognes Steve E. | Dir | S - Sale | $23.79 | -1,727 | 32.7K | -5% | -$41.1K | |
| D | 2024-08-01 | 2024-07-31 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | M - OptEx | $0.00 | +154 | 9,448 | +2% | $0 |
| M | 2024-07-03 | 2024-06-13+ | DNLI | Denali Therapeutics Inc. | Krognes Steve E. | Dir | S - Sale | $22.11 | -30.7K | 34.5K | -47% | -$678.7K |
| D | 2024-07-02 | 2024-06-30 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | M - OptEx | $0.00 | +154 | 9,294 | +2% | $0 |
| D | 2024-06-13 | 2024-06-12 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | M - OptEx | $0.00 | +5,592 | 9,140 | +158% | $0 |
| D | 2024-06-04 | 2024-05-31 | DNLI | Denali Therapeutics Inc. | Krognes Steve E. | Dir | A - Grant | $0.00 | +5,967 | 53.3K | +13% | $0 |
| D | 2024-06-03 | 2024-05-31 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | M - OptEx | $0.00 | +155 | 3,548 | +5% | $0 |
| D | 2024-05-02 | 2024-04-30 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | M - OptEx | $0.00 | +154 | 3,393 | +5% | $0 |
| 2024-04-02 | 2024-04-01 | DNLI | Denali Therapeutics Inc. | Krognes Steve E. | Dir | S - Sale | $20.50 | -92.5K | 47.3K | -66% | -$1.90M | |
| D | 2024-04-01 | 2024-03-31 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | M - OptEx | $0.00 | +154 | 3,239 | +5% | $0 |
| D | 2024-03-01 | 2024-02-29 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | M - OptEx | $0.00 | +154 | 3,085 | +5% | $0 |
| 2024-02-15 | 2024-02-13 | DNLI | Denali Therapeutics Inc. | Krognes Steve E. | Dir | S - Sale | $17.29 | -2,750 | 139.8K | -2% | -$47.5K | |
| D | 2024-02-01 | 2024-01-31 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | M - OptEx | $0.00 | +155 | 2,931 | +6% | $0 |
| 2024-01-09 | 2024-01-05 | DNLI | Denali Therapeutics Inc. | Krognes Steve E. | Dir | S - Sale | $19.43 | -3,208 | 142.6K | -2% | -$62.3K | |
| D | 2024-01-02 | 2023-12-31 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | M - OptEx | $0.00 | +154 | 2,776 | +6% | $0 |
| D | 2023-12-04 | 2023-11-30 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | M - OptEx | $0.00 | +154 | 2,622 | +6% | $0 |
| D | 2023-11-01 | 2023-10-31 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | M - OptEx | $0.00 | +154 | 2,468 | +7% | $0 |
| D | 2023-10-02 | 2023-09-30 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | M - OptEx | $0.00 | +155 | 2,314 | +7% | $0 |
| D | 2023-09-05 | 2023-08-31 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | M - OptEx | $0.00 | +154 | 2,159 | +8% | $0 |
| 2023-08-23 | 2023-08-21 | DNLI | Denali Therapeutics Inc. | Krognes Steve E. | Dir | S - Sale | $22.60 | -1,419 | 145.8K | -1.0% | -$32.1K | |
| D | 2023-08-01 | 2023-07-31 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | M - OptEx | $0.00 | +154 | 2,005 | +8% | $0 |
| D | 2023-07-05 | 2023-06-30 | GH | Guardant Health, Inc. | Krognes Steve E. | Dir | M - OptEx | $0.00 | +1,851 | 1,851 | New | $0 |
| D | 2023-06-05 | 2023-06-01 | DNLI | Denali Therapeutics Inc. | Krognes Steve E. | Dir | A - Grant | $0.00 | +4,216 | 147.2K | +3% | $0 |
| 2023-02-15 | 2023-02-13 | DNLI | Denali Therapeutics Inc. | Krognes Steve E. | Dir | S - Sale | $30.10 | -2,119 | 143.0K | -1% | -$63.8K | |
| 2023-02-10 | 2023-02-08 | DNLI | Denali Therapeutics Inc. | Krognes Steve E. | Dir | S - Sale | $30.88 | -1,377 | 145.1K | -0.9% | -$42.5K | |
| 2023-01-09 | 2023-01-05 | DNLI | Denali Therapeutics Inc. | Krognes Steve E. | Dir | S - Sale | $28.44 | -2,970 | 146.5K | -2% | -$84.5K | |
| 2022-08-23 | 2022-08-19 | DNLI | Denali Therapeutics Inc. | Krognes Steve E. | Dir | S - Sale | $33.22 | -2,253 | 149.5K | -1% | -$74.8K | |
| D | 2022-07-21 | 2022-07-19 | DNLI | Denali Therapeutics Inc. | Krognes Steve E. | Dir | M - OptEx | $0.68 | +62.5K | 151.7K | +70% | +$42.5K |
| 2022-02-15 | 2022-02-11 | DNLI | Denali Therapeutics Inc. | Krognes Steve E. | CFO, Treas | S - Sale | $34.69 | -2,560 | 120.2K | -2% | -$88.8K | |
| 2022-02-11 | 2022-02-09 | DNLI | Denali Therapeutics Inc. | Krognes Steve E. | CFO, Treas | S - Sale | $37.09 | -1,296 | 122.8K | -1% | -$48.1K | |
| 2022-01-07 | 2022-01-05 | DNLI | Denali Therapeutics Inc. | Krognes Steve E. | CFO, Treas | S - Sale | $44.75 | -2,225 | 124.1K | -2% | -$99.6K | |
| D | 2022-01-05 | 2022-01-03 | DNLI | Denali Therapeutics Inc. | Krognes Steve E. | CFO, Treas | A - Grant | $0.00 | +31.0K | 126.3K | +33% | $0 |
| M | 2021-08-23 | 2021-08-19 | DNLI | Denali Therapeutics Inc. | Krognes Steve E. | CFO, Treas | S - Sale | $49.57 | -2,285 | 95.3K | -2% | -$113.3K |
Purchase Sale Sale after option exercise All abbreviations